Amble Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This white powder compound has shown promising results in metabolic research applications.
Our pharmaceutical grade Amble Tirzepatide is produced under strict quality control measures to ensure consistent purity and performance in research settings. The product is particularly noted for its potential applications in metabolic syndrome and weight management studies.
The compound is supplied in vacuum-sealed vials to maintain stability, with various concentration options available. Each batch is accompanied by comprehensive analytical documentation to verify purity and composition.
For research use only. Not for human consumption. Proper storage conditions are essential to maintain the integrity of this peptide compound.